CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 9, 2013, Pages 5213-5223

  Zhai, Jin Xia ^a   Zou, Li Wei ^a   Zhang, Zhao Xiang ^a   Fan, Wen Jing ^a   Wang, Han Yong ^a   Liu, Ting ^a   Ren, Zheng ^a   Dai, Rui Xue ^a   Ye, Dongqing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

CTLA 4; Meta analysis; Polymorphism; Systemic lupus erythematosus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; ASIAN; CONTROLLED STUDY; CTLA 4 GENE; DISEASE ASSOCIATION; ETHNICITY; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; PROMOTER REGION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; COMPUTATIONAL BIOLOGY; CTLA-4 ANTIGEN; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84883279621     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2125-7     Document Type: Article

References (44)

1. D'Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369(9561):587-596
2. Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA (2010) Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol 6(3):461-479
3. Powell JJ, Van de Water J, Gershwin ME (1999) Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 107(Suppl 5):667-672
4. Sestak AL, Furnrohr BG, Harley JB, Merrill JT, Namjou B (2011) The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 70(Suppl 1):i37-i43
5. Manolio TA, Collins FS, Cox NJ et al (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747-753
6. Hussain N, Jaffery G, Sabri AN, Hasnain S (2011) HLA association in SLE patients from Lahore-Pakistan. Bosn J Basic Med Sci. 11(1):20-26
7. Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G, Mysirlaki H, Vazgiourakis V, Sidiropoulos P, Niewold TB, Boumpas DT (2011) Goulielmos GN Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 20(5):501-506
8. Aranda F, Wingeyer SP, Muñoz SA, Allievi A, Orden A, Trobo R, Alvarez A, Eimon A, Barreira JC, Schneeberger E, Sarano J, Hofman J, de Larrañaga G (2012) The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study. Eur Cytokine Netw 23(1):7-11
9. Zervou MI, Vazgiourakis VM, Yilmaz N, Kontaki E, Trouw LA, Toes RE, Bicakcigil M, Boumpas DT, Yavuz S, Goulielmos GN (2011) TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey. Hum Immunol 72(12):1210-1213
10. Cunninghame Graham DS, Wong AK, McHugh NJ, Whittaker JC, Vyse TJ (2006) Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 15(21):3195-3205
11. Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, Barr SG, Zummer M, Genes Investigators, Fortin PR, Wither J, Rioux JD (2011) A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 12(1):51-58
12. Taha Khalaf A, Song JQ, Gao TT, Yu XP, Lei TC (2011) CTLA-4 gene polymorphism and the risk of systemic lupus erythematosus in the Chinese population. J Biomed Biotechnol 2011:167395 PMCID: PMC3170903
13. Chua KH, Puah SM, Chew CH, Tan SY, Lian LH (2010) Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 37(2):274-280
14. Lee YH, Kim YR, Ji JD, Sohn J, Song GG (2001) Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus 10(9):601-605
15. Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T (2001) Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 40(6):662-667
16. Gang C, Jiahui Y, Huaizhou W, Qing C, Dongbao Z, Qian S (2009) Defects of mitogen-activated protein kinase in ICOS signaling pathway lead to CD4(+) and CD8(+) T-cell dysfunction in patients with active SLE. Cell Immunol 258(1):83-89
17. Contin-Bordes C, Lazaro E, Richez C, Jacquemin C, Caubet O, Douchet I, Viallard JF, Moreau JF, Pellegrin JL, Blanco P (2011) Expansion of myelin autoreactive CD8 + T lymphocytes in patients with neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis 70(5):868-871
18. Smolen JS, Chused TM, Leiserson WN, Reeves JP, Alling D, Steinberg AD (1982) Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Am J Med 72(5):783-790
19. McInerney MF, Clough JD, Seniztzer D, Cathcart MK (1988) Two distinct subsets of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 49(1):116-132
20. Chavele KM, Ehrenstein MR (2011) Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 585(23):3603-3610
21. Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102-115
22. Schuler PJ, Schilling B, Harasymczuk M, Hoffmann T, Johnson J, Lang S, Whiteside TL (2012) Phenotypic and functional characteristics of ATP-hydrolysing CD4(+) CD39(+) FOXP3(+) and CD4(+) CD39(+) FOXP3(neg) T-cell subsets in patients with cancer. Eur J Immunol 42(7):1876-1885
23. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277(48):46478-46486
24. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2(3):145-152
25. Wang XB, Zhao X, Giscombe R, Lefvert AK (2002) A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 3(4):233-234
26. Lee YH, Harley JB, Nath SK (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 116(5):361-367
27. Ulker M, Yazisiz V, Sallakci N, Avci AB, Sanlioglu S, Yegin O, Terzioglu E (2009) CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. Int J Immunogenet 36(4):245-250
28. Kimkong I, Nakkuntod J, Sae-Ngow S, Snabboon T, Avihingsanon Y, Hirankarn N (2011) Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population. Asian Pac J Allergy Immunol 29(3):229-235
29. Xu AP, Yin PD, Su XY (2004) Association of CTLA-4 promoter -1722 polymorphism with systemic lupus erythematosus in Chinese. Di Yi Jun Yi Da Xue Xue Bao 24(10):1107-1112
30. Takeuchi F, Kuwata S, Mori M (2005) CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus. J Rheumatol 32(10):2062
31. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(109):629-634
32. Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, Oka T, Juji T, Yamane A, Tokunaga K (1999) Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54(6):578-584
33. Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC (1999) The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 58(3):193-195
34. Pullmann R Jr, Lukác J, Skerenová M, Rovensky J, Hybenová J, Melus V, Celec S, Pullmann R, Hyrdel R (1999) Cytotoxic T-lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 17(6):725-729
35. D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P (2000) Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 43(1):120-128
36. Liu MF, Wang CR, Lin LC, Wu CR (2001) CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10(9):647-649
37. Hudson LL, Rocca K, Song YW, Pandey JP (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111(4-5):452-455
38. Aguilar F, Torres B, Sánchez-Román J, Núñez- Roldán A, González-Escribano MF (2003) CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol 64(10):936-940
39. Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K (2003) CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 21(4):527-528
40. Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM (2004) Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 12(8):620-626
41. George C, Tsokos MD (2011) Systemic lupus erythematosus. N Engl J Med 365:2110-2121
42. Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC (2012) Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950 to 2000 s. Semin Arthritis Rheum 41(6):830-839
43. Lee YH, Lee HS, Choi SJ, Ji JD, Song GG (2012) Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. Inflamm Res 61(2):135-141
44. Egger M, Smith GD (1997) Meta-analysis. Potentials and promise. BMJ 315(7119):1371-1374